Back to results

Wake Forest University

Targeting tGLI1-positive Breast Cancer with Ketoconazole

Abstract

dc:description.abstract

Despite improvements in early detection and therapies, breast cancer remains the second leading cause of cancer-related death in women and the second most common cancer to metastasize to the brain. Current standard of care for breast cancer brain metastases (BCBM) involves surgical resection of individual lesions and whole brain radiotherapy (WBRT) for multiple lesions, however, effective FDA-approved drugs for patients with intracranial progression remain an area of unmet need. Our laboratory discovered an alternative splice variant of glioma-associated oncogene homolog 1 (GLI1) in glioblastoma (GBM), termed truncated GLI1 (tGLI1), that is a gain-of-function GLI1 transcription factor and demonstrates tumor-specific expression. Previous results in our laboratory have implicated tGLI1 in promoting breast cancer stem cells (CSCs) and BCBM. These potent oncogenic and metastasis-promoting effects and tumor-specific expression make tGLI1 an ideal therapeutic target. Using a synthetic lethality chemical screen approach, we found that ketoconazole, an FDA-approved azole antifungal, was able to kill tGLI1-expressing cancer cells with increased efficacy against the CSC subpopulation. Additionally, ketoconazole selectively inhibited the progression of tGLI1-positive BCBM in vivo. Mechanistic studies suggest that ketoconazole-dependent cell kill is, in part, mediated through downregulation of the stemness genes CD44 and OCT4. Collectively, our results demonstrate that ketoconazole is an effective inhibitor of CSCs and brain metastasis of tGLI1-positive breast cancer. These findings provide the rationale to further develop novel tGLI1 inhibitors, based on the structure of ketoconazole for the treatment of BCBM.

Degree

thesis:*
Grantor dc:publisher
Wake Forest University
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Doheny, Daniel Lawrence

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/10339/93054
OAI identifier oai:identifier
oai:wakespace.lib.wfu.edu:10339/93054

Chain of custody

source
Harvested from
Wake Forest University
Base URL
wakespace.lib.wfu.edu/oai/request
Last updated
2026-07-27
Source record
OAI-PMH GetRecord
related terms
citation

Doheny, Daniel Lawrence. Targeting tGLI1-positive Breast Cancer with Ketoconazole. Wake Forest University, 2018. http://hdl.handle.net/10339/93054